Tue, February 10, 2009
[ Tue, Feb 10th 2009 ]: Market Wire
Tenet Announces Definitive Agreement to Sell USC University Hospital
[ Tue, Feb 10th 2009 ]: Market Wire
NeuroMetrix, Inc. Reports Total Revenues of $7.2 Million for the Fourth Quarter of 2008
[ Tue, Feb 10th 2009 ]: Market Wire
Enzon Announces IND Acceptance for Its Survivin Antagonist
[ Tue, Feb 10th 2009 ]: Market Wire
Oculus Innovative Sciences to Present at the Roth .. l Partners 21st Annual OC Growth Stock Conference
[ Tue, Feb 10th 2009 ]: Market Wire
Cougar Biotechnology Announces Agreement with FDA .. nt for Phase III Trial of CB7630 (Abiraterone Ace
[ Tue, Feb 10th 2009 ]: Market Wire
PPD to Receive Milestone Payments for First Regul .. Dapoxetine) in Finland and Sweden for Treatment o
[ Tue, Feb 10th 2009 ]: Market Wire
NMT Medical Appoints Board Member Frank Martin Interim President & Chief Executive Officer
[ Tue, Feb 10th 2009 ]: Market Wire
Alnylam Receives Grant of New Patent Broadly Covering RNAi Therapeutics
[ Tue, Feb 10th 2009 ]: Market Wire
Quidel to Hold 2008 Fourth Quarter and Year-End F .. cial Results Conference Call on February 25, 2009
[ Tue, Feb 10th 2009 ]: Market Wire
Progenics Selects Subcutaneous Form of PRO 140, a .. vel HIV Antibody Therapy, for Further Development
[ Tue, Feb 10th 2009 ]: Market Wire
Synta Pharmaceuticals Announces First Patient Tre .. Elesclomol Monotherapy Solid Tumor Clinical Study
[ Tue, Feb 10th 2009 ]: Market Wire
Curis Reports Fourth Quarter and Year-End 2008 Financial Results
[ Tue, Feb 10th 2009 ]: Market Wire
Reflect Scientific: Reflect Scientific, Inc. Receives a $200,000 Order for CatPro 5000 System
[ Tue, Feb 10th 2009 ]: Market Wire
Inspire Elects Alan F. Holmer to Board of Directors
[ Tue, Feb 10th 2009 ]: Market Wire
VIVUS Initiates Second Pivotal Phase 3 Trial of Avanafil for Treatment of Erectile Dysfunction
[ Tue, Feb 10th 2009 ]: Market Wire
Natus to Present at the Roth Capital Partners 21st Annual Growth Stock Conference
[ Tue, Feb 10th 2009 ]: Market Wire
Cubist Plans to Commence Patent Infringement Liti .. nteral Medicines, Inc. In Response To ANDA filing
[ Tue, Feb 10th 2009 ]: Market Wire
Dyax and Fovea Sign Development and Commercializa .. ion Agreement for DX-88 in Ophthalmic Indications
[ Tue, Feb 10th 2009 ]: Market Wire
Bioject Extends Supply Agreement with Ferring Pharmaceuticals, Inc.
Mon, February 9, 2009
[ Mon, Feb 09th 2009 ]: Market Wire
Clinical Data Announces Third Quarter Fiscal 2009 Financial Results
[ Mon, Feb 09th 2009 ]: Market Wire
Orthofix International Raises Concerns About Another Ramius Nominee for Orthofix Board
[ Mon, Feb 09th 2009 ]: Market Wire
Forbes Medi-Tech Inc.: Leading Healthy Lifestyle .. y Proven Benefits of Forbes Medi-Tech's Cholester
[ Mon, Feb 09th 2009 ]: Market Wire
Allana Resources Inc.: Allana Resources Initiates .. nnaissance Surveys on Potash Resource in Ethiopia
[ Mon, Feb 09th 2009 ]: Market Wire
Oculus Innovative Sciences? Security Holders Exer .. any as Result of Recently Announced Strategic Inv
[ Mon, Feb 09th 2009 ]: Market Wire
Genta Incorporated to Release Fourth Quarter Financial Results and Host Conference Call
[ Mon, Feb 09th 2009 ]: Market Wire
Curis Announces Collaborative Agreement between G .. nentech and National Cancer Institute on GDC-0449
[ Mon, Feb 09th 2009 ]: Market Wire
Synovis Life Technologies to Present at 21st Annu .. Capital Partners Growth Stock Conference Feb. 18
[ Mon, Feb 09th 2009 ]: Market Wire
Ligand Earns $1 Million Milestone Payment on Progress of Drug Candidate for Alzheimer?s Disease
[ Mon, Feb 09th 2009 ]: Market Wire
Oculus Innovative Sciences Announces Fiscal Third .. and Corporate Update Release and Conference Call
[ Mon, Feb 09th 2009 ]: Market Wire
UnitedHealth Group Awarded LEED® Green Building Certification
[ Mon, Feb 09th 2009 ]: Market Wire
Synta Pharmaceuticals Names Dr. Vojo Vukovic, Vice President, Clinical Research
[ Mon, Feb 09th 2009 ]: Market Wire
Theragenics Corporation® Announces Schedule for Fourth Quarter and Year-End 2008 Conference Call
[ Mon, Feb 09th 2009 ]: Market Wire
Compugen Appoints Dov Hershberg Chairman of the Board
[ Mon, Feb 09th 2009 ]: Market Wire
Inhibitex Completes Phase I Clinical Trials for F .. ad HCV Compounds for Advanced Preclinical Studies
[ Mon, Feb 09th 2009 ]: Market Wire
Dynavax Announces Receipt of Communication from the U.S. FDA on HEPLISAVTM Hepatitis B Vaccine
[ Mon, Feb 09th 2009 ]: Market Wire
SciClone Pharmaceuticals, Inc.: SciClone Issues G .. hrough to Profitability for the Full Year of 2009
[ Mon, Feb 09th 2009 ]: Market Wire
EPIX Pharmaceuticals Provides Update on NASDAQ Listing Status
[ Mon, Feb 09th 2009 ]: Market Wire
Zacks Bull & Bear of the Day Highlights: Biogen Idec, CEMEX, Ford, Tata Motors and Carmike Cinemas
Sun, February 8, 2009
[ Sun, Feb 08th 2009 ]: Market Wire
Riassunto: Nei pazienti affetti da sclerosi multi .. malattia non manifesta attivit per due anni, seco
[ Sun, Feb 08th 2009 ]: Market Wire
MS Patients Treated with TYSABRI® Remain Free of .. s, According to Data Published in the Lancet Neur
Fri, February 6, 2009
[ Fri, Feb 06th 2009 ]: Market Wire
Celgene Corporation to Present at the 11th Annual BIO CEO Investor Conference
[ Fri, Feb 06th 2009 ]: Market Wire
Proton Laboratories Inc.: Proton Labs to Begin Bottling Functional Water
[ Fri, Feb 06th 2009 ]: Market Wire
Geron to Present at BIO CEO & Investor Conference
[ Fri, Feb 06th 2009 ]: Market Wire
MEDNAX to Present at UBS Global Healthcare Conference
[ Fri, Feb 06th 2009 ]: Market Wire
Gilead Sciences to Present at the 11th Annual BIO CEO Investor Conference on Tuesday, February 10
[ Fri, Feb 06th 2009 ]: Market Wire
Span-America Announces Termination of Hill-Rom Supply Contract
[ Fri, Feb 06th 2009 ]: Market Wire
CIGNA Announces Appearance at the UBS Global Healthcare Services Conference
[ Fri, Feb 06th 2009 ]: Market Wire
Odyssey Healthcare to Broadcast Its Fourth Quarte .. ear-End 2008 Conference Call Live on the Internet
[ Fri, Feb 06th 2009 ]: Market Wire
LifePoint Hospitals to Broadcast Its Fourth Quart .. ear-End 2008 Conference Call Live on the Internet
[ Fri, Feb 06th 2009 ]: Market Wire
AspenBio Pharma, Inc.: AspenBio Pharma to Present .. l Partners 21st Annual OC Growth Stock Conference
[ Fri, Feb 06th 2009 ]: Market Wire
Advanced Medical Optics, Inc. Gives Notice of Ant .. nd Merger to Holders of Convertible Senior Subord
[ Fri, Feb 06th 2009 ]: Market Wire
Aeolus Pharmaceuticals Announces First Quarter Fiscal Year 2009 Financial Results
[ Fri, Feb 06th 2009 ]: Market Wire
Medtronic Completes Acquisition of Ablation Frontiers
[ Fri, Feb 06th 2009 ]: Market Wire
Ligand Enters into Screening Agreement with Trevena
[ Fri, Feb 06th 2009 ]: Market Wire
Biogen Idec Receives Shareholder Proposal
[ Fri, Feb 06th 2009 ]: Market Wire
Health Management Associates, Inc. Announces Four .. ear-End 2008 Earnings Conference Call and Webcast
[ Fri, Feb 06th 2009 ]: Market Wire
The Genome Center at Washington University Scales-Up on Illumina Sequencers
Thu, February 5, 2009
[ Thu, Feb 05th 2009 ]: Market Wire
Aetna Awarded $150,000 to Northern California Nonprofits in 2008
[ Thu, Feb 05th 2009 ]: Market Wire
FORTIS: Fortis publishes explanatory document on voting at General Meeting
[ Thu, Feb 05th 2009 ]: Market Wire
SCOR: Prestigious Redmayne report recognises SCOR .. d Protection reinsurance in the United Kingdom an
[ Thu, Feb 05th 2009 ]: Market Wire
Targacept to Report Fourth Quarter and 2008 Financial Results on February 12, 2009
[ Thu, Feb 05th 2009 ]: Market Wire
CONMED Corporation: CONMED Corporation Announces Fourth Quarter and Full Year 2008 Results
[ Thu, Feb 05th 2009 ]: Market Wire
Certified Diabetic Services, Inc. Terminates Asset Purchase Agreement
[ Thu, Feb 05th 2009 ]: Market Wire
BioSante Pharmaceuticals, Inc. To Present At BIO CEO and Investor Conference and ISSWSH Conference
[ Thu, Feb 05th 2009 ]: Market Wire
Progen-Avexa Merger Notice of Meeting and Independent Expert Report
[ Thu, Feb 05th 2009 ]: Market Wire
GeneThera: GeneThera Offers Discounted Johne's Di .. ted by Government's Call to Eliminate 400,000 Hea
[ Thu, Feb 05th 2009 ]: Market Wire
Applied Biosystems Awards Genomic Research Grant to St. Jude Children?s Research Hospital
[ Thu, Feb 05th 2009 ]: Market Wire
StemCells, Inc. to Present at the 11th Annual BIO CEO & Investor Conference
[ Thu, Feb 05th 2009 ]: Market Wire
Dr. Reddy?s Announces Five ANDA Approvals and Generic Product Launches in the US Market
[ Thu, Feb 05th 2009 ]: Market Wire
GTx, Inc. Announces Fourth Quarter and Year End 2008 Corporate Results Conference Call and Webcast
[ Thu, Feb 05th 2009 ]: Market Wire
BioDelivery Sciences Announces Initial Results of Phase 1 Clinical Study of Bioral Amphotericin B
[ Thu, Feb 05th 2009 ]: Market Wire
Cytori Patent Allowance Expands Celution® System .. n for Adipose Stem & Regenerative Cell Processing
[ Thu, Feb 05th 2009 ]: Market Wire
Health Management Associates, Inc. to Present at .. he 2009 UBS Global Healthcare Services Conference
[ Thu, Feb 05th 2009 ]: Market Wire
Zacks Bull & Bear of the Day Highlights: Myriad G .. , School Specialty, Exxon, Chevron and Transocean
[ Thu, Feb 05th 2009 ]: Market Wire
Illumina Presents Development Roadmap for Scaling its Genome Analyzer
[ Thu, Feb 05th 2009 ]: Market Wire
Exelixis Announces February 10 Webcast of Present .. at the 11th Annual BIO CEO & Investor Conference
Wed, February 4, 2009
[ Wed, Feb 04th 2009 ]: Market Wire
Sun Healthcare Group, Inc.: Sun Healthcare Group, .. ; Schedules Conference Call to Announce 2008 Earn
[ Wed, Feb 04th 2009 ]: Market Wire
NPS Pharmaceuticals to Present at BIO CEO & Investor Conference
[ Wed, Feb 04th 2009 ]: Market Wire
Toxin Alert Inc.: Andersen Resigns From Toxin Alert Board
[ Wed, Feb 04th 2009 ]: Market Wire
Inhibitex to Present at the 11th Annual BIO CEO & Investor Conference
[ Wed, Feb 04th 2009 ]: Market Wire
Urigen Pharmaceuticals: Urigen Announces Recent Insider Purchases Total Over 500,000 Shares
[ Wed, Feb 04th 2009 ]: Market Wire
Theravance, Inc.: GSK and Theravance announce pos .. nce-daily fluticasone furoate in the treatment of
[ Wed, Feb 04th 2009 ]: Market Wire
Helicos Announces Improved Performance of Its Hel .. pe" Single Molecule Sequencer and tSMS" Chemistry
[ Wed, Feb 04th 2009 ]: Market Wire
Biofield Corp. Expands Arsenal Of Non-Invasive Diagnostic Devices
[ Wed, Feb 04th 2009 ]: Market Wire
Bio-Imaging Technologies to Release Fourth Quarte .. Results and Host Conference Call on February 11,
[ Wed, Feb 04th 2009 ]: Market Wire
Oragenics, Inc., Announces Agreement with Garden of Life, Inc., for Use of ProBiora3
[ Wed, Feb 04th 2009 ]: Market Wire
Progenics Appoints Peter J. Crowley as Independent Board Member
[ Wed, Feb 04th 2009 ]: Market Wire
UnitedHealth Group Makes It Simpler for Physician .. nister Health Care with Updated Customer ID Cards
[ Wed, Feb 04th 2009 ]: Market Wire
EXACT Sciences Announces Issuance of Key Patent C .. ing Vimentin Gene for Colorectal Cancer Screening
[ Wed, Feb 04th 2009 ]: Market Wire
Applied Biosystems Delivers Integrated, Application-Focused Solutions on New SOLiD 3 System
[ Wed, Feb 04th 2009 ]: Market Wire
Auxilium Pharmaceuticals, Inc.: Auxilium Pharmace .. arter and Full Year 2008 Results and Conduct Conf
[ Wed, Feb 04th 2009 ]: Market Wire
MEDNAX, Inc. Acquires Neonatal Practice
[ Wed, Feb 04th 2009 ]: Market Wire
Compugen Ltd. to Review Fourth Quarter and Year-E .. Financial Results on Wednesday, February 11, 2009
[ Wed, Feb 04th 2009 ]: Market Wire
Sequenom to Hold Fourth Quarter and Full Year 200 .. Financial Results Conference Call on February 11
[ Wed, Feb 04th 2009 ]: Market Wire
Xenomics, Inc. Restructures and Extends Maturity of Convertible Debentures
Tue, February 3, 2009
[ Tue, Feb 03rd 2009 ]: Market Wire
Community Health Systems to Participate in the 2009 UBS Global Healthcare Services Conference
[ Tue, Feb 03rd 2009 ]: Market Wire
NexMed Announces Sale of U.S. Rights for Topical Erectile Dysfunction Treatment
[ Tue, Feb 03rd 2009 ]: Market Wire
ACADIA Pharmaceuticals to Present at the BIO CEO & Investor Conference on February 10, 2009
[ Tue, Feb 03rd 2009 ]: Market Wire
BioReference Laboratories, Inc to Speak at The UBS Global Healthcare Services Conference
[ Tue, Feb 03rd 2009 ]: Market Wire
Response Genetics Signs Agreement With Roche Diagnostics to Support Cancer Test Development
[ Tue, Feb 03rd 2009 ]: Market Wire
Affymax to Present at BIO CEO and Investor Conference
[ Tue, Feb 03rd 2009 ]: Market Wire
King Pharmaceuticals Announces Corporate Restructuring to Reduce Operating Expenses
[ Tue, Feb 03rd 2009 ]: Market Wire
PerkinElmer Expands LED Portfolio with Acquisition of Opto Technology, Inc.
[ Tue, Feb 03rd 2009 ]: Market Wire
Myriad Genetics: Myriad Genetics, Inc. Reports Results for Second Quarter of Fiscal 2009
[ Tue, Feb 03rd 2009 ]: Market Wire
Sequenom Announces Findings on Methylation Markers and RNA-SNP Markers as Presented at SMFM
[ Tue, Feb 03rd 2009 ]: Market Wire
Amarin to Present at the 11th Annual BIO CEO & Investor Conference
[ Tue, Feb 03rd 2009 ]: Market Wire
Reflect Scientific: $400,000 Order for Newly Rele .. 7000 System Received by Reflect Scientific, Inc.
[ Tue, Feb 03rd 2009 ]: Market Wire
Acorda Therapeutics to Present at the 11th Annual BIO CEO & Investor Conference
[ Tue, Feb 03rd 2009 ]: Market Wire
Amedisys Acquires Two Home Health Agencies in Arizona
[ Tue, Feb 03rd 2009 ]: Market Wire
GTx Announces Webcast of Corporate Presentation at the 11th Annual BIO CEO & Investor Conference
[ Tue, Feb 03rd 2009 ]: Market Wire
CeragenixAchieves 120 Daysof Antimicrobial Efficacy on Treated Silicone Medical Device.
[ Tue, Feb 03rd 2009 ]: Market Wire
Inspire Announces Webcast of Presentation at BIO CEO Conference
[ Tue, Feb 03rd 2009 ]: Market Wire
Compugen Announces Discovery of Biomarker Candida .. ian Cancer and Signing of Collaboration Agreement
[ Tue, Feb 03rd 2009 ]: Market Wire
Endologix to Hold 2008 Fourth Quarter and Full Ye .. Financial Results Conference Call on February 19
Mon, February 2, 2009
[ Mon, Feb 02nd 2009 ]: Market Wire
Kindred Healthcare to Present at the UBS Global Healthcare Services Conference
[ Mon, Feb 02nd 2009 ]: Market Wire
LHC Group and Ochsner Health System Complete Home Health Joint Venture
[ Mon, Feb 02nd 2009 ]: Market Wire
Corcept Therapeutics: CORLUX(R) Mitigates Weight .. al(R), Expands on Proof of Concept Established in
[ Mon, Feb 02nd 2009 ]: Market Wire
Ligand Announces Phase IIb Results With DARA
[ Mon, Feb 02nd 2009 ]: Market Wire
Medtronic Completes Enrollment in Global Head-to-Head Stent-Safety Study
[ Mon, Feb 02nd 2009 ]: Market Wire
Wright Medical Group, Inc. to Host Fourth Quarter 2008 Earnings Conference Call
[ Mon, Feb 02nd 2009 ]: Market Wire
Allos Therapeutics to Present at the 2009 BIO CEO & Investor Conference
[ Mon, Feb 02nd 2009 ]: Market Wire
Aetna Awarded $600,000 to Non-Profits in Maryland, Virginia and the District of Columbia
[ Mon, Feb 02nd 2009 ]: Market Wire
ZIOPHARM Oncology to Present at the 11th Annual BIO CEO & Investor Conference
[ Mon, Feb 02nd 2009 ]: Market Wire
Synta Completes Enrollment of the Phase 3 SYMMETR .. ial of Elesclomol in Stage IV Metastatic Melanoma
[ Mon, Feb 02nd 2009 ]: Market Wire
Community Health Systems, Inc. Announces the Acquisition of Siloam Springs, Arkansas Hospital
[ Mon, Feb 02nd 2009 ]: Market Wire
Auxilium Pharmaceuticals, Inc.: Auxilium Pharmace .. llment in Phase IIb Clinical Trial of XIAFLEX(TM)
[ Mon, Feb 02nd 2009 ]: Market Wire
Ceragenix and Hyphens Enter Into Distribution and Supply Agreement for EpiCeram®
[ Mon, Feb 02nd 2009 ]: Market Wire
Idera Pharmaceuticals Announces Achievement of Cl .. ollaboration with Merck KGaA for Cancer Treatment
[ Mon, Feb 02nd 2009 ]: Market Wire
Acorda Therapeutics Submits New Drug Application .. ment of Walking Ability in People with Multiple S
[ Mon, Feb 02nd 2009 ]: Market Wire
LifePoint Hospitals Acquires Rockdale Medical Center
[ Mon, Feb 02nd 2009 ]: Market Wire
SciClone Pharmaceuticals, Inc.: SciClone Pharmace .. icals to Present at BIO CEO & Investor Conference
[ Mon, Feb 02nd 2009 ]: Market Wire
Syneron Medical Ltd.: Syneron Medical Announces M .. Strengthening of Syneron's Leadership Position in
[ Mon, Feb 02nd 2009 ]: Market Wire
ZymoGenetics to Host Conference Call and Webcast .. , 2009 to Discuss 2008 Year-End Financial Results
Sun, February 1, 2009
[ Sun, Feb 01st 2009 ]: Market Wire
FORTIS: Fortis holding announcement
Sat, January 31, 2009
[ Sat, Jan 31st 2009 ]: Market Wire
FORTIS: Fortis holding publishes addendum to shareholder circular
[ Sat, Jan 31st 2009 ]: Market Wire
Resumen: REVLIMID® recibe recomendacin prelimina .. nal para la Salud y la Excelencia Clnica (NICE en
[ Sat, Jan 31st 2009 ]: Market Wire
REVLIMID® riceve indicazione preliminare positiv .. ealth and Clinical Excellence (NICE) per l'uso ne
[ Sat, Jan 31st 2009 ]: Market Wire
REVLIMID® erhlt die vorlufige Empfehlung des bri .. r Health and Clinical Excellence (NICE) zur Anwen
[ Sat, Jan 31st 2009 ]: Market Wire
REVLIMID® reoit un avis pr©alable favorable de .. et de l'excellence clinique (INEC) pour tre util
[ Sat, Jan 31st 2009 ]: Market Wire
REVLIMID® ontvangt positieve aanbeveling van het .. and Clinical Excellence (NICE) voor gebruik in d
Fri, January 30, 2009
[ Fri, Jan 30th 2009 ]: Market Wire
Biodel to Report First Quarter Fiscal Year 2009 R .. sults of Bioequivalence Study on February 5, 2009
[ Fri, Jan 30th 2009 ]: Market Wire
Abiomed Third Fiscal Quarter 2009 Earnings and Conference Call Notification
[ Fri, Jan 30th 2009 ]: Market Wire
Teva Announces Approval of Generic Risperdal® Oral Solution
[ Fri, Jan 30th 2009 ]: Market Wire
ZOLL Announces Filing of Patent Infringement Suit .. Alsius Corporation and Alsius Medical Corporation
[ Fri, Jan 30th 2009 ]: Market Wire
Daxor Corp.: Daxor Announces Tahlequah City Hospi .. lequah, OK Acquires BVA-100 Blood Volume Analyzer
[ Fri, Jan 30th 2009 ]: Market Wire
First Patient Treated in Adipose Stem & Regenerative Cell Study for Stress Urinary Incontinence
[ Fri, Jan 30th 2009 ]: Market Wire
DexCom Announces Pricing of Public Offering of Common Stock
[ Fri, Jan 30th 2009 ]: Market Wire
Health Management Associates, Inc. to Present at .. lobal High Yield and Leveraged Finance Conference
[ Fri, Jan 30th 2009 ]: Market Wire
GeneThera: Dr. Antonio Milici of GeneThera Nomina .. for National Advisory Committee on Meat & Poultry
[ Fri, Jan 30th 2009 ]: Market Wire
CONMED Corporation: CONMED Corporation to Announc .. uarter 2008 Financial Results on February 5, 2009
[ Fri, Jan 30th 2009 ]: Market Wire
King Pharmaceuticals Announces Positive Results f .. ety and Efficacy Study of EMBEDA" Extended Releas
[ Fri, Jan 30th 2009 ]: Market Wire
Progen-Avexa Merger Update
[ Fri, Jan 30th 2009 ]: Market Wire
St. Jude Medical Announces 2009 Annual Investor Conference
[ Fri, Jan 30th 2009 ]: Market Wire
SonoSite Introduces Powerful New Turbo Technology for S Series"
[ Fri, Jan 30th 2009 ]: Market Wire
GTx Congratulates Dr. Duane D. Miller on His Indu .. Chemical Society Medicinal Chemistry Hall of Fame
[ Fri, Jan 30th 2009 ]: Market Wire
Hollis-Eden Pharmaceuticals to Present at 2009 BIO CEO and Investor Conference
[ Fri, Jan 30th 2009 ]: Market Wire
Forbes Names Illumina America?s Fastest-Growing Technology Company for Second Time
[ Fri, Jan 30th 2009 ]: Market Wire
REVLIMID® Receives Preliminary Positive Recommen .. for Health and Clinical Excellence (NICE) for Us
[ Fri, Jan 30th 2009 ]: Market Wire
Santarus Submits New Drug Application for ZEGERID Tablet Product
Thu, January 29, 2009
[ Thu, Jan 29th 2009 ]: Market Wire
EXACT Sciences Regains NASDAQ Compliance
[ Thu, Jan 29th 2009 ]: Market Wire
CompCare Acquires Core Corporate Consulting Group, Inc.
[ Thu, Jan 29th 2009 ]: Market Wire
DUSA Pharmaceuticals, Inc.: DUSA Elects Alexander Casdin to Board of Directors
[ Thu, Jan 29th 2009 ]: Market Wire
Seattle Genetics to Host Conference Call and Webc .. ter and Year 2008 Financial Results on February 5
[ Thu, Jan 29th 2009 ]: Market Wire
Aetna Awarded $125,000 to North Carolina Non-Profits
[ Thu, Jan 29th 2009 ]: Market Wire
Aetna Awarded $725,000 to Georgia Non-Profits
[ Thu, Jan 29th 2009 ]: Market Wire
Aetna Awarded $857,500 to Non-Profits in Florida
[ Thu, Jan 29th 2009 ]: Market Wire
Bio-Imaging Technologies to Present at the UBS Gl .. erence on February 9, 2009 at the Waldorf Astoria
[ Thu, Jan 29th 2009 ]: Market Wire
Eurand N.V.: FDA Accepts Eurand's Response to Approvable Letter for EUR-1008 as Complete
[ Thu, Jan 29th 2009 ]: Market Wire
Synta Pharmaceuticals to Present at the BIO CEO & Investor Conference 2009
[ Thu, Jan 29th 2009 ]: Market Wire
Humana and Wisconsin Health Information Exchange Announce Collaborative Business Program
[ Thu, Jan 29th 2009 ]: Market Wire
ARIAD to Webcast Conference Call on Fourth Quarter and Year-End 2008 Financial Results
[ Thu, Jan 29th 2009 ]: Market Wire
University of Texas at Austin Acquires SOLiD System to Advance Genomic Research
[ Thu, Jan 29th 2009 ]: Market Wire
Alexion?s Soliris(R) (eculizumab) Receives Marketing Approval in Canada for All Patients with PNH
[ Thu, Jan 29th 2009 ]: Market Wire
Spectranetics Announces Executive Appointments to Further Enhance Compliance Programs
[ Thu, Jan 29th 2009 ]: Market Wire
Transcend Reports 18% Revenue Growth, 28% Increas .. in Pre-Tax Income and Earnings Per Share of $.17
[ Thu, Jan 29th 2009 ]: Market Wire
POZEN Informed by FDA That Endoscopic Gastric Ulc .. ce Continues to Be an Acceptable Primary Endpoint
[ Thu, Jan 29th 2009 ]: Market Wire
Micrus Endovascular to Hold Fiscal 2009 Third Quarter Conference Call on February 5
Wed, January 28, 2009
[ Wed, Jan 28th 2009 ]: Market Wire
Enzon Nominates Two New Candidates for Its Board of Directors
[ Wed, Jan 28th 2009 ]: Market Wire
Aetna Announces 2009 Annual Meeting Details
[ Wed, Jan 28th 2009 ]: Market Wire
HealthSpring To Present At 2009 UBS Global Healthcare Services Conference
[ Wed, Jan 28th 2009 ]: Market Wire
CombinatoRx Publishes Data on Selective Amplification of Synergistic Combination Drug Candidate
[ Wed, Jan 28th 2009 ]: Market Wire
Positron Corporation?s Joint Venture Submits FDA 510(k) for its Attrius" PET Scanner
[ Wed, Jan 28th 2009 ]: Market Wire
Hansen Medical, Inc.: Hansen Medical Announces 2008 Fourth Quarter Conference Call
[ Wed, Jan 28th 2009 ]: Market Wire
Vitro Receives Notice of Allowance for Adult Stem .. rom the United States Patent and Trademark Office
[ Wed, Jan 28th 2009 ]: Market Wire
Resumen: Gilead esboza las prioridades de I+D para 2009
[ Wed, Jan 28th 2009 ]: Market Wire
Samenvatting: Gilead zet prioriteiten O&O uiteen voor 2009
[ Wed, Jan 28th 2009 ]: Market Wire
Gilead gibt Schwerpunkte fr Forschung und Entwicklung 2009 bekannt
[ Wed, Jan 28th 2009 ]: Market Wire
Seattle Genetics Announces Pricing of Common Stock Offering
[ Wed, Jan 28th 2009 ]: Market Wire
Synovis Life Technologies to Webcast Fiscal First .. r Earnings Conference Call Wednesday, February 25
[ Wed, Jan 28th 2009 ]: Market Wire
Geron Announces John Walker Resigns as Director
[ Wed, Jan 28th 2009 ]: Market Wire
Sequenom Terminates Exchange Offer to Acquire EXACT Sciences
[ Wed, Jan 28th 2009 ]: Market Wire
Medtronic Expands CURE-AF Clinical Program into Europe and Canada
[ Wed, Jan 28th 2009 ]: Market Wire
ImmunoGen, Inc. Announces Webcast of its Investment Community Meeting on February 27, 2009
[ Wed, Jan 28th 2009 ]: Market Wire
U.S. FDA Approves OraQuick ADVANCE® 12-Month Shelf Life Dating
[ Wed, Jan 28th 2009 ]: Market Wire
ZymoGenetics Secures Worldwide Rights to IL-21
Tue, January 27, 2009
[ Tue, Jan 27th 2009 ]: Market Wire
FORTIS: Fortis holding confirms negotiations with Belgian government and BNP Paribas
[ Tue, Jan 27th 2009 ]: Market Wire
Allana Resources Inc.: CORRECTION: Allana Resourc .. ication on Engagement of Investor Relations Group
[ Tue, Jan 27th 2009 ]: Market Wire
American Medical Systems Announces Changes to Wor .. ructure; Increased Focus on International Markets
[ Tue, Jan 27th 2009 ]: Market Wire
Samenvatting: Gilead Sciences meldt financile recordresultaten over vierde kwartaal en geheel 2008
[ Tue, Jan 27th 2009 ]: Market Wire
ZYNEX Announces AMEX Application Status

NexMed to Present at the 11th Annual BIO CEO & Investor Conference


  Copy link into your clipboard //health-fitness.news-articles.net/content/2009/ .. the-11th-annual-bio-ceo-investor-conference.html
  Print publication without navigation Published in Health and Fitness on , Last Modified on 2009-02-03 10:57:07 by Market Wire


EAST WINDSOR, N.J.--([ BUSINESS WIRE ])--NexMed, Inc. (Nasdaq: NEXM), a developer of products based on the NexACT® drug delivery technology, today announced that Vivian Liu, Chief Executive Officer, will present an overview of the company at the BIO CEO & Investor Conference on Tuesday, February 10, 2009 at 11 am (ET) at the Waldorf Astoria Hotel in New York City.

BIO CEO is the largest independent investor conference focused on leading publicly traded biotech companies, and is designed to appeal to public market investors as well as the sell-side investment community, in addition to business development executives from global pharmaceutical and biotechnology companies.

Interested parties may access the live webcast of NexMed's presentation on the Company's website (Investors: News & Events) at [ http://www.nexmed.com ].

About NexMed

NexMed, Inc. leverages its proprietary NexACT drug delivery technology to develop innovative topical pharmaceutical products that address unmet medical needs. NexMed's novel onychomycosis treatment is licensed to Novartis for global development. NexMed's pipeline also includes its late stage alprostadil treatment for erectile dysfunction, a Phase 2 treatment for female sexual arousal disorder, and an early stage treatment for psoriasis. For further information about NexMed, go to [ www.nexmed.com ].


Publication Contributing Sources